Queue, a company dedicated to automating prescription fulfillment, has emerged from stealth with a $12.6 million seed funding round aimed at revolutionizing the pharmacy industry. The company's autonomous pharmacy system promises faster, more accessible, and cost-effective prescription services, critical in an industry plagued by labor shortages and financial pressures.
What Happened
Queue, co-founded by Nick Desai and Josh Liu, is leveraging robotics and artificial intelligence to address the structural challenges facing the U.S. pharmacy market. The company’s system can fill and verify prescriptions without an on-site pharmacist, using robotic cells that process a vial of 60 pills every 30 seconds. With support for 280 of the most prescribed medications, Queue aims to reduce costs by up to 96% compared to traditional pharmacies. The system also adheres to rigorous safety and verification protocols, ensuring 100% accuracy in drug dispensing.
The U.S. retail pharmacy market, valued at $670.6 billion, is under strain due to pharmacist shortages and financial losses from "negative reimbursements." With nearly one in three pharmacies closing since 2010, the industry is in dire need of innovation. Queue's solution offers a potential lifeline, especially for rural and underserved communities.
What This Means for Your Business
For AECM professionals, Queue's advancement represents a significant shift in healthcare infrastructure. The company's technology could reshape pharmacy construction and renovation projects, integrating autonomous systems into new builds and retrofits. Contractors and engineers could see increased demand for facilities equipped to handle robotic pharmacy systems, potentially leading to new federal funding opportunities for projects aimed at improving healthcare access.
Compliance officers and procurement directors should note the implications for supply chain management and security protocols, as Queue's system requires integration with existing healthcare networks while maintaining stringent safety standards. Furthermore, this innovation could influence competitive positioning, as businesses that adopt such technologies may gain an edge in cost efficiency and service delivery.
What US Operators Should Watch
Operators should monitor Queue's deployment timelines, especially as the company has already secured a major national pharmacy chain as a customer. The rollout of these systems could signal new procurement windows for related technologies and services. Additionally, stakeholders should stay informed about potential regulatory changes that could arise from the adoption of autonomous systems in healthcare settings.
As the industry grapples with workforce shortages and financial pressures, Queue's robotic pharmacy system could become a critical component in the evolution of healthcare delivery in the United States.
Source: https://www.therobotreport.com/queue-raises-funding-fully-autonomous-pharmacy/. Read the original story ->
Is your firm ready for what’s next?
VisioneerIT helps AECM and government contractors modernize operations, achieve compliance, and implement AI.
Explore VisioneerIT Solutions →Tracking the right federal opportunities?
OryonIQ's AI platform monitors agency forecasts, contract awards, and procurement timelines — so government contractors always know what’s coming next.
Try OryonIQ Free →
